Du forlater nå lundbeck.com/no

Denne lenken tar deg til en ny nettside. På nettsiden er det egne brukervilkår vedrørende innhold og koblinger som Lundbeck Norge ikke tar ansvar for.

 

Fortsett til nettside

Avbryt

Organisasjon og eierskap

Hvordan vi er organisert

Lundbeck har vært oppført på Nasdaq København siden 1999. Vår største aksjonær er Lundbeck-stiftelsen, som årlig distribuerer rundt 500 millioner danske kroner til ulike forskningsstipender. Stiftelsen eier omtrent 70 % av aksjene i Lundbeck, mens de resterende 30 % blir notert på børsen.   

Our business units

research and development

Our research and development (R&D) teams are dedicated to creating the most innovative and effective treatments for patients with psychiatric and neurological disorders. We are the only fully-integrated pharmaceutical company in the world solely devoted to the treatment of these disorders – and we are passionate about what we do. Our research facilities are located in Denmark and the United States and we have production facilities in France, Italy, and Denmark.

commercial operations

Our commercial operations team are represented globally, and we have affiliates in 50+ countries. The Lundbeck global marketing team at our headquarters in the Danish capital, Copenhagen, shapes our global brand strategy. It works closely alongside R&D,  business development, and other key business areas. Commercial Operations is responsible for all commercial activities in Lundbeck and drives the sales and marketing of Lundbeck products across the world via our affiliates.In additional markets we sell Lundbeck products via partners and distributors.The division is co-led by Executive Vice Presidents and is divided into three main areas: Regions, Global Strategic Marketing and Business Operations.

corporate functions

Our corporate functions provide dedicated support to our business within Finance, IT & Digitalization, Legal, Compliance & Sustainability, Procurement, and Investor Relations to ensure business value. We support our global organization from our headquarters in Copenhagen and our business service center in Krakow. Our affiliates in over 50 countries also have their own in-house corporate functions.

product development and supply

This is the core of our manufacturing unit. It offers significant opportunities for engineers within chemistry, production, supply chain, engineering, and maintenance.The product development and supply team is formed from specialist skillsets across the organization. They manage the entire project lifecycle – from user requirement specifications and vendor selections through to installation, qualification/validation, and final handover to the end user. 

sales

Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for brain diseases. With our 70-year heritage, we have been trusted partners within the medical community. Lundbeck is unique from other biopharmaceutical companies because of our ownership structure - we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and continue to bring forward symptomatic therapies to help people live better lives. 

 

people and communication

People & Communication consists of two business units – Corporate HR and Corporate Communication & Public Affairs. We support all our employees with HR and Communication related tasks across various business areas and geographies. In corporate HR, we aim to optimize Lundbeck’s global potential by developing people, the organization, attracting new employees and with operations and with operational excellence. Our Corporate Communication & Public Affairs department drives and facilitates communication to activate the Lundbeck brand, engage employees and ensure their understanding of strategic priorities.  

Composition of ownership, end 2021

Mer om Lundbeck